Dr. Akbar Rizvi, MD

  • Mckinney, TX
  • Hematologist and oncologist
NPI1225023948PAC ID7012945843
Medicare services, 2024
90,087
Medicare patients, 2024
412
Part D claims, 2024
1,793
MIPS score, 2024
85
Hospital affiliations
2
Practice address
4510 Medical Center Dr, Mckinney, TX 75069
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Medical City Surgery Center McKinney - HOPD

Acute Care Hospital outpatient department · Mckinney, Texas

See all 6 affiliations

Find Dr. Rizvi's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Akbar Rizvi is a hematologist and oncologist in Mckinney, Texas

Dr. Rizvi practices at Medical City Surgery Center McKinney - HOPD in Mckinney, Texas.

Dr. Rizvi's NPI, 1225023948, was assigned on September 19, 2005. Dr. Rizvi graduated from Dow University of Health Sciences in 1990. Dr. Rizvi holds Texas license M2049.

NPI and contact details
Medicare PAC ID
7012945843
NPI enumeration date
September 19, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
63
Medical school graduation
1990

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Akbar Rizvi practices at Medical City Surgery Center McKinney - HOPD in Mckinney, Texas

Dr. Rizvi's primary practice is Medical City Surgery Center McKinney - HOPD, at 4510 Medical Center Dr, Mckinney, TX 75069.

  • Medical City Surgery Center McKinney - HOPD
    4510 Medical Center Dr, Mckinney, TX 75069

Source: Dmand AI Affiliation Data

Dr. Akbar Rizvi is affiliated with 5 sites of care and 1 medical group

Dr. Rizvi's primary practice is Medical City Surgery Center McKinney - HOPD in Mckinney, Texas. Dr. Rizvi is also affiliated with Medical City McKinney Hospital. The medical group on file is Texas Oncology. Dmand AI also links Dr. Rizvi to 1 more hospital, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

See all 6 affiliations for Dr. Rizvi

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Akbar Rizvi's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rizvi practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Medical City Surgery Center McKinney - HOPDAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Rizvi practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Akbar Rizvi is one of 814 hematologists and oncologists in Texas

Hematology and oncology is Dr. Rizvi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rizvi is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Rizvi's licenses on file in 2 states: Texas and Pennsylvania.

Specialties and state licenses

  • Hematology and oncology, TexasPrimaryLicense M2049 · 2005 to 2027 · taxonomy 207RH0003X
  • Pennsylvania license1995 to 1996

Clinical focus

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Rizvi treats.

Hematologists and oncologists near Dr. Rizvi

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

814hematologists and oncologists in Texas
7hematologists and oncologists in Mckinney

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Akbar Rizvi billed Medicare for 90,087 services in 2024

CMS data shows 90,087 Medicare services from Dr. Rizvi across 47 procedure codes in 2024, for 412 Medicare patients. Medicare paid $1,037,622 for them.

Medicare services, 202490,087
Medicare patients412
Paid by Medicare$1M
Procedure codes47

Dr. Rizvi's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 84,4032024: 81,0984%
Lab and pathology
2023: 3,6622024: 3,29410%
Tests and treatments
2023: 2,6042024: 2,32711%
Office and hospital visits
2023: 2,0622024: 1,64320%
Surgery
2023: 1,1622024: 1,33715%
Other services
2023: 1572024: 355126%
Imaging
2023: 422024: 3321%

Where Dr. Rizvi's Medicare services took place, 2024

  • In an office89,834100%
  • In a facility2530%

Dr. Rizvi compared with the Texas median for hematologists and oncologists, 2024

  • Dr. Rizvi
  • Texas median
Medicare services
90,087vs 1,16277.5 times
Medicare patients
412vs 25164% above
Part D claims
1,468vs 4893.0 times

Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.

Dr. Rizvi's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Rizvi

Need commercial claims for Dr. Rizvi?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rizvi and other hematologists and oncologists in Texas.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Akbar Rizvi treated 412 Medicare patients in 2024, average age 74

CMS counts 412 Medicare patients who saw Dr. Rizvi in 2024. The largest group is 65 to 74, with 175 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rizvi's median patient age at 67, with 59% women.

Medicare patients, 2024412
Average age74
Average risk score2.12
Also on Medicaid13%

Dr. Rizvi's Medicare patients by age, 2024

Dr. Rizvi's Medicare patients by sex, 2024

  • Women23958%
  • Men17342%

Chronic conditions among Dr. Rizvi's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis49%
  4. Chronic kidney disease42%
  5. Diabetes40%
  6. Ischemic heart disease40%
  7. Cancer37%
  8. Mood disorders33%

Share of Medicare patients with each condition. A patient can have several.

Dr. Rizvi's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women59%
  • Men39%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Akbar Rizvi wrote 1,793 Medicare Part D claims in 2024

In 2024, Dr. Rizvi wrote 1,793 Medicare Part D claims for 237 patients. 83% of them were for generic drugs. CMS names the drug for 1,468 of them, across 43 drugs with 11 or more claims each, at $1,097,770 in total drug cost. In 2023, CMS named 1,548 claims across 41 drugs.

Part D claims, 20241,793
Drugs named by CMS43
Total drug cost$1.1M
Part D patients237

Dr. Rizvi's Part D claims by kind of drug, 2024

  • Generic1,495 claims83%
  • Brand-name298 claims17%

Dr. Rizvi's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Rizvi's Part D claims, 2024

  • Opioids15%270 of 1,793 claims
  • Antibiotics5%95 of 1,793 claims
  • Antipsychotics, patients 65 and over1%12 of 1,793 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,5482024: 1,4685%

Drugs named by CMS: 43 in 2024, 41 in 2023.

See all prescribing by Dr. Rizvi

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Akbar Rizvi scored 85 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Rizvi for performance year 2024, reported through an alternative payment model (APM). Dr. Rizvi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rizvi as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Rizvi's MIPS scores, performance year 2024

  • 85of 100Final score
  • 67.5of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Rizvi by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Akbar Rizvi received $9,601 in industry payments from 2016 to 2025

CMS Open Payments shows 491 general payments to Dr. Rizvi from 61 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,272.

General payments to Dr. Rizvi by program year, 2016 to 2025

General payments to Dr. Rizvi by kind, 2016 to 2025

$9.6Kin total
  • Food and beverage$7,89682%
  • Education$1,02311%
  • Device or supply loans$6827%

Companies that paid Dr. Rizvi the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Rizvi

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Akbar Rizvi graduated from Dow University of Health Sciences

Dr. Rizvi graduated from Dow University of Health Sciences in 1990.

  1. Medical schoolDow University of Health Sciences
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Akbar Rizvi accepts plans from 22 insurance carriers

Dr. Rizvi is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.

Plan types Dr. Rizvi accepts, by number of carriers

  1. PPO13
  2. HMO12
  3. Medicare10
  4. POS6
  5. EPO4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Akbar Rizvi's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Akbar Rizvi

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Akbar Rizvi's NPI number?

Dr. Akbar Rizvi's NPI number is 1225023948. It was assigned on September 19, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Akbar Rizvi?

Dr. Akbar Rizvi is a hematologist and oncologist in Mckinney, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Akbar Rizvi practice?

Dr. Rizvi practices at 4510 Medical Center Dr, Mckinney, TX 75069. Dr. Rizvi's primary practice is Medical City Surgery Center McKinney - HOPD in Mckinney, Texas. Dmand AI also links Dr. Rizvi to 1 hospital, 1 group practice or clinic and 1 ambulatory surgery center.

What is Dr. Akbar Rizvi's medical license number?

Dr. Rizvi holds Texas license M2049, one of the licenses on file in 2 states.

Which states has Dr. Akbar Rizvi been licensed in?

Dmand AI has state licenses on file for Dr. Rizvi in Texas (2005 to 2027) and Pennsylvania (1995 to 1996).

Which hospitals is Dr. Akbar Rizvi affiliated with?

Dr. Rizvi is affiliated with Medical City McKinney Hospital. Dmand AI links Dr. Rizvi to 1 more hospital.

What medical group is Dr. Akbar Rizvi part of?

Dr. Rizvi is linked to Texas Oncology.

Does Dr. Akbar Rizvi accept Medicare?

Yes. CMS data shows Dr. Rizvi billed Medicare for 90,087 services in 2024, and Dr. Rizvi accepts Medicare assignment.

Does Dr. Akbar Rizvi offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Rizvi as offering telehealth services.

What is Dr. Akbar Rizvi's MIPS score?

Dr. Rizvi's MIPS final score for performance year 2024 is 85 out of 100, reported through an alternative payment model (APM).

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Akbar Rizvi see?

CMS counts 412 Medicare patients who saw Dr. Rizvi in 2024, with an average age of 74.

Is Dr. Akbar Rizvi board certified?

Yes. Dr. Rizvi is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Akbar Rizvi bill to Medicare?

In 2024, Dr. Rizvi's most billed Medicare services were injected or infused drug (J1453), injected or infused drug (J1756) and injected or infused drug (J9267).

Where did Dr. Akbar Rizvi go to medical school?

Dr. Rizvi graduated from Dow University of Health Sciences in 1990.

What drugs does Dr. Akbar Rizvi prescribe most?

In 2024 Medicare Part D data, Dr. Rizvi's most prescribed drugs by claims were Hydrocodone-Acetaminophen, Eliquis and Letrozole.

Has Dr. Akbar Rizvi received payments from drug or device companies?

CMS Open Payments shows $9,601 in general payments to Dr. Rizvi from 61 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Akbar Rizvi been practicing?

Dr. Rizvi graduated from medical school in 1990, 36 years ago.

What insurance does Dr. Akbar Rizvi accept?

Dr. Rizvi is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)